Madison Roberts is a Freelance Food & Travel Writer. She specializes in exploring culinary experiences and travel destinations, contributing her insights to notable publications such as Condé Nast Traveler, People Magazine, and Cosmopolitan. Madison's work has also been featured in Redbook Magazine and various regional newspapers, showcasing her diverse writing portfolio and commitment to sharing compelling stories.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
Not enough data
Not enough data
This information evolves through artificial intelligence and human feedback. Improve this profile .
By: Madison Roberts
Take Enveric Biosciences (NASDAQ: ENVB), a company that’s been flying under the radar while building an IP fortress around a novel class of non-hallucinogenic neuroplastogens. Now, that fortress is being tested, as Gilgamesh Pharmaceuticals moves to challenge Enveric’s patent claims, just weeks after AbbVie announced its $1.2 billion acquisition of Gilgamesh’s lead compound, Bretisilocin (GM-2505).
Nursing students from Falmouth recently celebrated ahead of their clinical experience at the annual Blessing of the Hands ceremonies at St. Anselm College and Emmanuel College.
